Concepedia

Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity

Emily C. Liang, Kai Rejeski, Teng Fei, Aya Albittar, Jennifer J. Huang, Andrew J. Portuguese, Qian Wu, Sandeep Raj, Marion Subklewe, Roni Shouval,

Bone Marrow Transplantation · 2024 · 16 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi, Larry D. Anderson, Nina Shah et al. · New England Journal of Medicine · 2021 · 2.4K citations · Full text

, , +17

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.7K citations

, , +17

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

, , +8

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez Perez, Pierre Sesques et al. · Blood · 2021 · 441 citations · Full text

, , +16

Early and late hematologic toxicity following CD19 CAR-T cells

Shalev Fried, Abraham Avigdor, Bella Bielorai et al. · Bone Marrow Transplantation · 2019 · 401 citations

, , +14